VYOME HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
VYOME HOLDINGS, INC. (HIND) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value of $2.30 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue · last filed 2026-08-12
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $2.30M.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $429.00K.
- 2020-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $125.00K.
- 2020-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $0.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value |
|---|---|
| 2026-06-30 | $2.30M 10-Q · filed 2026-08-12 |
| 2025-06-30 | $429.00K 8-K · filed 2025-09-02 |
| 2020-09-30 | $125.00K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $0.00 10-Q · filed 2020-07-30 |
| 2020-03-31 | $0.00 10-Q · filed 2020-06-19 |
| 2019-12-31 | $9.00K 10-K · filed 2020-02-27 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-08 |
| 2019-06-30 | $0.00 10-Q · filed 2019-07-24 |
| 2019-03-31 | $209.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $531.00K 10-K · filed 2019-02-22 |
| 2018-09-30 | $1.17M 10-Q · filed 2018-11-02 |
| 2018-06-30 | $608.00K 10-Q · filed 2018-08-02 |
| 2018-03-31 | $1.73M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $5.02M 10-K · filed 2018-03-05 |
| 2017-09-30 | $9.23B 10-Q · filed 2017-11-03 |
| 2017-06-30 | $9.98B 10-Q · filed 2017-08-02 |
| 2017-03-31 | $11.74M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $7.79M 10-K · filed 2017-02-23 |
| 2016-09-30 | $14.30M 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |